-
2
-
-
0013612267
-
Regulating drug prices: The West Germany and British experience
-
Hancher L, Moran M, editors. Oxford: Clarendon Press
-
Hancher L. Regulating drug prices: the West Germany and British experience. In: Hancher L, Moran M, editors. Capitalism, culture and economic regulation. Oxford: Clarendon Press, 1989
-
(1989)
Capitalism, Culture and Economic Regulation
-
-
Hancher, L.1
-
5
-
-
4243096064
-
The politics of the pharmaceutical price regulation scheme
-
Streek W, Schmitter PC, editors. London: Sage
-
Sargent JA. The politics of the pharmaceutical price regulation scheme. In: Streek W, Schmitter PC, editors. Private interest government: beyond market and state. London: Sage, 1987
-
(1987)
Private Interest Government: Beyond Market and State
-
-
Sargent, J.A.1
-
6
-
-
0041713260
-
The cost-containment issue: A study of government-industry relations in the pharmaceutical sectors of the United Kingdom and West Germany
-
Wilks S, Wright M, editors. Oxford: Clarendon Press
-
Macmillan K, Turner I. The cost-containment issue: a study of government-industry relations in the pharmaceutical sectors of the United Kingdom and West Germany. In: Wilks S, Wright M, editors. Comparative government-industry relations: Western Germany, the United States and Japan. Oxford: Clarendon Press, 1987
-
(1987)
Comparative Government-Industry Relations: Western Germany, the United States and Japan
-
-
Macmillan, K.1
Turner, I.2
-
10
-
-
0013615795
-
-
London: The Institute of Economic Affairs - Health and Welfare Unit
-
Reekie WD. Prescribing the price of pharmaceuticals. London: The Institute of Economic Affairs - Health and Welfare Unit, 1995: 26
-
(1995)
Prescribing the Price of Pharmaceuticals
, pp. 26
-
-
Reekie, W.D.1
-
11
-
-
0003200782
-
Thirty years of pharmaceutical price regulations: Developments in the National Health Service Price Regulation Scheme since 1957
-
Teeling Smith G, editor. London: Office of Health Economics
-
Luce TRH. Thirty years of pharmaceutical price regulations: developments in the National Health Service Price Regulation Scheme since 1957. In: Teeling Smith G, editor. Costs and benefits of pharmaceutical research. London: Office of Health Economics, 1987: 28-31
-
(1987)
Costs and Benefits of Pharmaceutical Research
, pp. 28-31
-
-
Luce, T.R.H.1
-
13
-
-
0029798750
-
The UK pharmaceutical market
-
Towse A. The UK pharmaceutical market. Pharmacoeconomics 1996; 10 Suppl. 2: 14-25
-
(1996)
Pharmacoeconomics
, vol.10
, Issue.SUPPL. 2
, pp. 14-25
-
-
Towse, A.1
-
14
-
-
0029744635
-
An historical survey of UK Government measures to control the NHS medicines expenditure from 1948 to 1996
-
Griffin J. An historical survey of UK Government measures to control the NHS medicines expenditure from 1948 to 1996. Pharmacoeconomics 1996; 10 (3): 210-24
-
(1996)
Pharmacoeconomics
, vol.10
, Issue.3
, pp. 210-224
-
-
Griffin, J.1
-
15
-
-
0000461062
-
Pricing dynamics in the pharmaceutical industry
-
Hudson J. Pricing dynamics in the pharmaceutical industry. Appl Econ 1992; 24: 103-12
-
(1992)
Appl Econ
, vol.24
, pp. 103-112
-
-
Hudson, J.1
-
16
-
-
0001090515
-
Behaviour of the firm under regulatory constraint
-
Averch H, Johnson L. Behaviour of the firm under regulatory constraint. Am Econ Rev 1962; 52: 1052-69
-
(1962)
Am Econ Rev
, vol.52
, pp. 1052-1069
-
-
Averch, H.1
Johnson, L.2
-
17
-
-
0001007821
-
Diversification incentives under 'price-based' and 'cost-based' regulation
-
Braeutigam RR, Panzar JC. Diversification incentives under 'price-based' and 'cost-based' regulation. Rand J Econ 1989; 20: 373-91
-
(1989)
Rand J Econ
, vol.20
, pp. 373-391
-
-
Braeutigam, R.R.1
Panzar, J.C.2
-
18
-
-
0013585875
-
Regulating firms with monopoly power
-
Sudgen R, editor. London: Routledge
-
Doyle C. Regulating firms with monopoly power. In: Sudgen R, editor. Industrial economic regulations. London: Routledge, 1993
-
(1993)
Industrial Economic Regulations
-
-
Doyle, C.1
-
19
-
-
0342376414
-
-
London: The Institute of Economic Affairs - Health and Welfare Unit
-
Burstall ML. 1992 and the pharmaceutical industry. London: The Institute of Economic Affairs - Health and Welfare Unit, 1990: 9
-
(1990)
1992 and the Pharmaceutical Industry
, pp. 9
-
-
Burstall, M.L.1
-
21
-
-
0028970240
-
Current prescribing in primary care in the UK: Effects of the indicative prescribing scheme and GP fundholding
-
Walley T, Wilson R, Bligh J. Current prescribing in primary care in the UK: effects of the indicative prescribing scheme and GP fundholding. Pharmacoeconomics 1995; 7 (4): 320-31
-
(1995)
Pharmacoeconomics
, vol.7
, Issue.4
, pp. 320-331
-
-
Walley, T.1
Wilson, R.2
Bligh, J.3
-
22
-
-
0000681385
-
Testing against general autoregressive and moving average error models when the regressors include lagged dependent variables
-
Godfrey LG. Testing against general autoregressive and moving average error models when the regressors include lagged dependent variables. Econometrica 1978; 46: 1293-301
-
(1978)
Econometrica
, vol.46
, pp. 1293-1301
-
-
Godfrey, L.G.1
-
23
-
-
84982371477
-
Testing for autocorrelation in dynamic linear models
-
Breusch TS. Testing for autocorrelation in dynamic linear models. Aust Econ Papers 1978; 17: 334-55
-
(1978)
Aust Econ Papers
, vol.17
, pp. 334-355
-
-
Breusch, T.S.1
|